Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SASLT practice guidelines: management of hepatitis C virus infection.
Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation. Alghamdi AS, et al. Among authors: alghamdi h. Saudi J Gastroenterol. 2012 Sep;18 Suppl(Suppl 1):S1-32. doi: 10.4103/1319-3767.101155. Saudi J Gastroenterol. 2012. PMID: 23006491 Free PMC article. No abstract available.
Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA. Sanai FM, et al. Among authors: alghamdi h. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28. Clin Gastroenterol Hepatol. 2013. PMID: 23811251
SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection.
Alghamdi AS, Alqutub A, Abaalkhail F, Sanai FM, Alghamdi H, Altraif I, Alswat KA, Alghamdi MY, Babatin MA, Alfaleh FZ. Alghamdi AS, et al. Among authors: alghamdi my, alghamdi h. Saudi J Gastroenterol. 2015 Mar-Apr;21(2):60-3. doi: 10.4103/1319-3767.153810. Saudi J Gastroenterol. 2015. PMID: 25843190 Free PMC article. Review. No abstract available.
SASLT guidelines: Update in treatment of Hepatitis C virus infection.
Alghamdi AS, Alghamdi M, Sanai FM, Alghamdi H, Aba-Alkhail F, Alswat K, Babatin M, Alqutub A, Altraif I, Alfaleh F. Alghamdi AS, et al. Among authors: alghamdi m, alghamdi h. Saudi J Gastroenterol. 2016 Aug;22 Suppl(Suppl 2):S25-57. doi: 10.4103/1319-3767.188067. Saudi J Gastroenterol. 2016. PMID: 27538727 Free PMC article. No abstract available.
Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
Altraif IH, Sanai F, Babatin MA, Alalwan AA, Abdo AA, Alhamoudi W, Peedikayil M, Alghamdi H, Alsohaibani F, Alswat KA, Murtaza S, Alghamdi A, Altraif S, Aljumah A, Handoo FA, AlBekairy AM, Al-Ashgar HI, Alquaiz M, Alblawi MA, AlTamimi W, Loustaud-Ratti V, Marquett P. Altraif IH, et al. Among authors: alghamdi a, alghamdi h. J Interferon Cytokine Res. 2017 Nov;37(11):488-493. doi: 10.1089/jir.2017.0054. J Interferon Cytokine Res. 2017. PMID: 29135370 Clinical Trial.
Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis.
Sanai FM, Altraif IH, Alswat K, AlZanbagi A, Babatin MA, AlMousa A, Almutairi NH, Aljawad MS, Alghamdi AS, Aljumah AA, Alalwan AM, Al-Hamoudi WK, Assiri AM, Dahlan Y, Alsahafi A, Alothmani HS, AlSaleemi MS, Mousa WA, Albenmousa A, Awny A, Albiladi H, Abdo AA, AlGhamdi H. Sanai FM, et al. Among authors: alghamdi as, alghamdi h. J Infect. 2018 Jun;76(6):536-542. doi: 10.1016/j.jinf.2018.04.001. Epub 2018 May 6. J Infect. 2018. PMID: 29742470
348 results